Merck & Co., Inc. is 48.8x more valuable than PTC THERAPEUTICS, INC. by market capitalization ($294.13 B vs $6.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PTCT | MRK |
|---|---|---|
| Market cap | $6.03 B | $294.13 B |
| US-listed rank | #1262 | #44 |
| Revenue (latest FY) | $1.73B | $65.01B |
| Net income (latest FY) | $683.00M | $18.25B |
| Net margin | 39.5% | 28.1% |
| P/E (trailing FY) | 8.8 | 16.1 |
| SEC filings | 1,262 | 996 |
Merck & Co., Inc. is 48.8x more valuable than PTC THERAPEUTICS, INC. by market capitalization ($294.13 B vs $6.03 B).
In their latest fiscal years, PTC THERAPEUTICS, INC. reported $1.73B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: PTC THERAPEUTICS, INC. and Merck & Co., Inc., or browse the full rankings.